Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Fortier

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|August 18, 2011
[Evaluation of an estrogen vaginal cream for the treatment of dyspareunia: a double-blind randomized trial]Sylvie Bazin, Jessica Lefebvre, Michel Fortier, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 16, 2022
Directive clinique n<sup>o</sup> 422g : Ménopause et ostéoporoseAliya A Khan, Hajar Abu Alrob, Dalal S Ali, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 16, 2022
Guideline No. 422g: Menopause and OsteoporosisAliya A Khan, Hajar Abu Alrob, Dalal S Ali, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|April 22, 2006
Canadian Consensus Conference on osteoporosis, 2006 updateJacques P Brown, Michel Fortier, Heather Frame, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 10, 2003
The management of uterine leiomyomasGuylaine Lefebvre, George Vilos, Catherine Allaire, et al.
The Journal of Sexual Medicine|April 30, 2014
Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal womenFernand Labrie, David Archer, Céline Bouchard, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 13, 2010
High internal consistency and efficacy of intravaginal DHEA for vaginal atrophyFernand Labrie, David Archer, Céline Bouchard, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|August 9, 2003
Emergency contraceptionSheila Dunn, Edith Guilbert, Guylaine Lefebvre, et al.
Menopause (New York, N.Y.)|May 14, 2009
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophyFernand Labrie, David Archer, Céline Bouchard, et al.
Menopause (New York, N.Y.)|May 9, 2009
Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal womenFernand Labrie, David Archer, Céline Bouchard, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|August 18, 2011
[Evaluation of an estrogen vaginal cream for the treatment of dyspareunia: a double-blind randomized trial]Sylvie Bazin, Jessica Lefebvre, Michel Fortier, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 16, 2022
Directive clinique n<sup>o</sup> 422g : Ménopause et ostéoporoseAliya A Khan, Hajar Abu Alrob, Dalal S Ali, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 16, 2022
Guideline No. 422g: Menopause and OsteoporosisAliya A Khan, Hajar Abu Alrob, Dalal S Ali, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|April 22, 2006
Canadian Consensus Conference on osteoporosis, 2006 updateJacques P Brown, Michel Fortier, Heather Frame, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 10, 2003
The management of uterine leiomyomasGuylaine Lefebvre, George Vilos, Catherine Allaire, et al.
The Journal of Sexual Medicine|April 30, 2014
Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal womenFernand Labrie, David Archer, Céline Bouchard, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 13, 2010
High internal consistency and efficacy of intravaginal DHEA for vaginal atrophyFernand Labrie, David Archer, Céline Bouchard, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|August 9, 2003
Emergency contraceptionSheila Dunn, Edith Guilbert, Guylaine Lefebvre, et al.
Menopause (New York, N.Y.)|May 14, 2009
Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophyFernand Labrie, David Archer, Céline Bouchard, et al.
Menopause (New York, N.Y.)|May 9, 2009
Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal womenFernand Labrie, David Archer, Céline Bouchard, et al.
Pageof 4